349 related articles for article (PubMed ID: 15623622)
1. High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2004 Dec; 10(24):8426-33. PubMed ID: 15623622
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
Spinazzi R; Andreis PG; Nussdorfer GG
Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
Körner M; Reubi JC
J Neuropathol Exp Neurol; 2008 Aug; 67(8):741-9. PubMed ID: 18648328
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y modulates steroid production of human adrenal H295R cells through Y1 receptors.
Kempná P; Körner M; Waser B; Hofer G; Nuoffer JM; Reubi JC; Flück CE
Mol Cell Endocrinol; 2010 Jan; 314(1):101-9. PubMed ID: 19699258
[TBL] [Abstract][Full Text] [Related]
5. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022
[TBL] [Abstract][Full Text] [Related]
6. Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors.
O'Hare MM; Schwartz TW
Cancer Res; 1989 Dec; 49(24 Pt 1):7010-4. PubMed ID: 2582442
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
8. NPY receptors in human cancer: a review of current knowledge.
Körner M; Reubi JC
Peptides; 2007 Feb; 28(2):419-25. PubMed ID: 17223228
[TBL] [Abstract][Full Text] [Related]
9. Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival.
Thouënnon E; Pierre A; Tanguy Y; Guillemot J; Manecka DL; Guérin M; Ouafik L; Muresan M; Klein M; Bertherat J; Lefebvre H; Plouin PF; Yon L; Anouar Y
Endocr Relat Cancer; 2010 Sep; 17(3):637-51. PubMed ID: 20483910
[TBL] [Abstract][Full Text] [Related]
10. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
[TBL] [Abstract][Full Text] [Related]
11. Identification of neuropeptide Y cleavage products in human blood to improve metabolic stability.
Khan IU; Reppich R; Beck-Sickinger AG
Biopolymers; 2007; 88(2):182-9. PubMed ID: 17206650
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the cloned atlantic cod neuropeptide Y-Yb receptor: peptide-binding requirements distinct from known mammalian Y receptors.
Sharma P; Arvidsson AK; Wraith A; Beck-Sickinger AG; Jönsson-Rylander AC; Larhammar D
Gen Comp Endocrinol; 1999 Sep; 115(3):422-8. PubMed ID: 10480994
[TBL] [Abstract][Full Text] [Related]
13. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
Amlal H; Faroqui S; Balasubramaniam A; Sheriff S
Cancer Res; 2006 Apr; 66(7):3706-14. PubMed ID: 16585197
[TBL] [Abstract][Full Text] [Related]
14. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
[TBL] [Abstract][Full Text] [Related]
15. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting.
Reubi C; Gugger M; Waser B
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):855-62. PubMed ID: 12111125
[TBL] [Abstract][Full Text] [Related]
16. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
Gehlert DR; Shaw JL
Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
[TBL] [Abstract][Full Text] [Related]
17. High expression of NPY receptors in the human testis.
Körner M; Waser B; Thalmann GN; Reubii JC
Mol Cell Endocrinol; 2011 Apr; 337(1-2):62-70. PubMed ID: 21295110
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
Umeda T; Kanatani A; Iwaasa H
Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors.
Cohen PS; Cooper MJ; Helman LJ; Thiele CJ; Seeger RC; Israel MA
Cancer Res; 1990 Sep; 50(18):6055-61. PubMed ID: 2393870
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y receptor expression in human primary ovarian neoplasms.
Körner M; Waser B; Reubi JC
Lab Invest; 2004 Jan; 84(1):71-80. PubMed ID: 14631382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
